首页|代谢相关脂肪性肝病与2型糖尿病的相关性研究进展

代谢相关脂肪性肝病与2型糖尿病的相关性研究进展

扫码查看
代谢相关脂肪性肝病(metabolic-associated fatty liver disease,MAFLD)和 2 型糖尿病(type 2 diabetes mellitus,T2DM)是两种常见的代谢性疾病,在全球范围内均有较高的个体患病率,二者合并的患病率呈上升趋势.MAFLD 与 T2DM 之间存在着复杂而紧密的联系,互为因果,共同促进心血管疾病、慢性肾病、肝脏相关并发症及肝外恶性肿瘤的发病.本文从流行病学、危险因素、病理生理机制、治疗等方面介绍了 MAFLD与 T2DM 之间的相关性.研究表明二者存在强烈的双向关系,MAFLD 是 T2DM 的独立危险因素,并且这种风险随着肝脏脂肪沉积的增加而增加,同时,T2DM 也可促进 MAFLD的发生发展.因此,在防治 MAFLD 的同时,也要重视 T2DM 的管理,以期提高患者的整体健康水平.
Research progress on the correlation between metabolic-associated fatty liver disease and type 2 diabetes mellitus
Metabolic-associated fatty liver disease(MAFLD)and type 2 diabetes mellitus(T2DM)is two common metabolic diseases with high individual prevalence worldwide,and the combined prevalence of the two diseases is on the rise.There is a complex and close association between MAFLD and T2DM,which is reciprocal causation and jointly promotes the incidence of cardiovascular disease,chronic kidney disease,liver-related complications and extrahepatic malignancies.This article introduced the correlation between MAFLD and T2DM from the aspects of epidemiology,risk factors,pathogenesis and therapy.The research shows that there is a strong bidirectional relationship between them.MAFLD was an independent risk factor for T2DM,and this risk increased with the increase of liver fat deposition.More-over,T2DM also promoted the occurrence and progression of MAFLD.Therefore,while preventing and treating MAFLD,we should also pay attention to the management of T2DM to improve the overall health of patients.

Metabolic-associated fatty liver diseaseType 2 diabetes mellitusEpidemiologyPathogenesisTherapy

赵娅芳、杨晋辉、郑梦瑶、杨黎宏

展开 >

昆明医科大学第二附属医院消化内科,云南 昆明 650101

代谢相关脂肪性肝病 2型糖尿病 流行病学 发病机制 治疗

国家自然科学基金昆明医科大学第二附属医院院内科技计划

821601062021yk018

2024

胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
年,卷(期):2024.33(8)